Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
March 7, 2019
Measurement of Collagen Cross-Links from Tissue Samples by Mass Spectrometry
Amar Joshi, Amna Zahoor, Alberto Buson
Scientific Reports
|
October 21, 2025
Robust IoT security using isolation forest and one class SVM algorithms
Amna Zahoor, Waseem Abbasi, Muhammad Zeeshan Babar, et al.
International Journal of Molecular Sciences
|
December 6, 2016
Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo
Siân P Cartland, Scott W Genner, Amna Zahoor, et al.
Journal of Molecular Graphics & Modelling
|
May 26, 2023
Synergistic modification of end groups in Quinoxaline fused core-based acceptor molecule to enhance its photovoltaic characteristics for superior organic solar cells
Sonia Sadiq, Muhammad Waqas, Amna Zahoor, et al.
Journal of Molecular Graphics & Modelling
|
September 2, 2023
A DFT study for improving the photovoltaic performance of organic solar cells by designing symmetric non-fullerene acceptors by quantum chemical modification on pre-existed LC81 molecule
Amna Zahoor, Sonia Sadiq, Rasheed Ahmad Khera, et al.
RSC Advances
|
February 27, 2023
Alteration of the central core of a DF-PCIC chromophore to boost the photovoltaic applications of non-fullerene acceptor based organic solar cells
Amna Zahoor, N M A Hadia, Sahar Javaid Akram, et al.
Scientific Reports
|
July 2, 2025
The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagement
Lara Perryman, Alison Findlay, Jana Baskar, et al.
Clinical and Translational Medicine
|
November 29, 2021
An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies
Alison Findlay, Craig Turner, Heidi Schilter, et al.
Journal of Cellular and Molecular Medicine
|
December 12, 2018
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis
Heidi Schilter, Alison D Findlay, Lara Perryman, et al.
Haematologica
|
April 17, 2025
A phase I / IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis
Pankit Vachhani, Peter Tan, Anne-Marie Watson, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
March 7, 2019
Measurement of Collagen Cross-Links from Tissue Samples by Mass Spectrometry
Amar Joshi, Amna Zahoor, Alberto Buson
Scientific Reports
|
October 21, 2025
Robust IoT security using isolation forest and one class SVM algorithms
Amna Zahoor, Waseem Abbasi, Muhammad Zeeshan Babar, et al.
International Journal of Molecular Sciences
|
December 6, 2016
Comparative Evaluation of TRAIL, FGF-2 and VEGF-A-Induced Angiogenesis In Vitro and In Vivo
Siân P Cartland, Scott W Genner, Amna Zahoor, et al.
Journal of Molecular Graphics & Modelling
|
May 26, 2023
Synergistic modification of end groups in Quinoxaline fused core-based acceptor molecule to enhance its photovoltaic characteristics for superior organic solar cells
Sonia Sadiq, Muhammad Waqas, Amna Zahoor, et al.
Journal of Molecular Graphics & Modelling
|
September 2, 2023
A DFT study for improving the photovoltaic performance of organic solar cells by designing symmetric non-fullerene acceptors by quantum chemical modification on pre-existed LC81 molecule
Amna Zahoor, Sonia Sadiq, Rasheed Ahmad Khera, et al.
RSC Advances
|
February 27, 2023
Alteration of the central core of a DF-PCIC chromophore to boost the photovoltaic applications of non-fullerene acceptor based organic solar cells
Amna Zahoor, N M A Hadia, Sahar Javaid Akram, et al.
Scientific Reports
|
July 2, 2025
The small molecule LOXL2 inhibitor SNT-5382 reduces cardiac fibrosis and achieves strong clinical target engagement
Lara Perryman, Alison Findlay, Jana Baskar, et al.
Clinical and Translational Medicine
|
November 29, 2021
An activity-based bioprobe differentiates a novel small molecule inhibitor from a LOXL2 antibody and provides renewed promise for anti-fibrotic therapeutic strategies
Alison Findlay, Craig Turner, Heidi Schilter, et al.
Journal of Cellular and Molecular Medicine
|
December 12, 2018
The lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis
Heidi Schilter, Alison D Findlay, Lara Perryman, et al.
Haematologica
|
April 17, 2025
A phase I / IIa trial of PXS-5505, a novel pan-lysyl oxidase inhibitor, in advanced myelofibrosis
Pankit Vachhani, Peter Tan, Anne-Marie Watson, et al.
Page
of 1